Management of Comorbidities in Kidney Disease in the 21st Century illustrates the breadth and accomplishment of investigators whose common bond is the extension of life.

Management of Comorbidities in Kidney Disease in the 21st Century summerizes the case for preventing vascular calcification rather than trating after-the-fact.

Contents

1. Hemoglobin predicts long-term survival in dialysis patients: A 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin
2. Prospective trials on anemia of chronic disease: the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)
3. Anemia of chronic Disease: Past, present, and future
4. Chronic kidney disease and cardiovascular disease in the Medicare population
5. Anemia as a risk factor for cardiovascular disease
6. Erythropoietin should be part of congestive heart failure management
7. Effect of erythropoietin on exercise capacity in anemic patients with advanced heart failure
8. Relationship of bioelectrical impedance parameters to nutrition and survival in peritoneal dialysis patients
9. Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease
10. Controversies in iron management
11. The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease
12. Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance
13. Malnutrition and inflammation in peritoneal dialysis patients
14. Serum albumin concentration in dialysis patients: Why does it remain resistant to therapy
15. Transforming growth factor beta and progression of renal disease
16. Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor
17. Overview of renal bone disease: Causes of treatment failure, clinical observations, the changing pattern of bone lesions, and future therapeutic approach
18. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure
19. An update on vitamin D as related to nephrology practice: 2003
20. The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal disease

Index

click here to see books of related interest